Research summary
Thymosin Alpha-1 — clinical & mechanistic profile
Thymosin alpha-1 is a 28-amino-acid thymic peptide that modulates immunity primarily through TLR-2 and TLR-9 agonism, promoting T-cell maturation, reversing T-cell exhaustion, activating NK cells, and balancing pro/anti-inflammatory responses. Approved in 35+ countries for viral hepatitis and cancer immunotherapy adjunct.
Research status
clinical investigational
Sequence
Ac-SDAAVDTSSEITTKDLKEKKEVVEEAEN
Molecular weight
3108.29 g/mol
Molecular formula
C129H215N33O55
Studied applications
- •TLR-2/TLR-9 agonism: engages Toll-like receptors on dendritic cells, triggering innate immune cascades
- •T-cell effects: elevates CD4+/CD8+ maturation, prevents apoptosis, reverses exhaustion in sepsis/COVID-19/HIV contexts
- •Anti-tumor activity: directly inhibits tumor proliferation and migration alongside immune stimulation
- •Hepatitis treatment: decreases inflammation, enhances antioxidant enzymes, reduces viral replication
- •Sepsis mortality reduction: meta-analysis indicates reduced 28-day mortality with T-cell restoration
- •HIV restoration: 2024 trial shows restored T-cell responses in HIV nonresponders
Mechanisms of action
- •TLR2/TLR9 signaling: engages Toll-like receptors on dendritic cells, activating NF-κB and JNK/p38/AP1 pathways
- •Dendritic cell activation: stimulates myeloid and plasmacytoid DCs to initiate adaptive immune responses
- •T-cell homeostasis: increases CD4+ and CD8+ maturation, prevents apoptosis, reverses exhaustion, modulates to avoid excessive activation
- •Anti-tumor direct action: inhibits tumor cell proliferation and migration via PTEN-mediated apoptosis and STAT3-MMP2 inhibition
- •Cytokine modulation: increases IFN-γ, IL-2, IL-3 production; reduces IL-1β and TNF-α for anti-inflammatory benefits
- •NK cell activation: enhances natural killer cell activity and MHC I/viral antigen presentation
Research constraints & safety notes
- •Not approved by FDA in the United States—approved in 35+ other countries
- •Clinical trials ongoing for various indications but not FDA approved for any
- •Effects are contextual—immunostimulatory in suppressed states, regulatory in hyperactivated states
- •Manufacturing requires complex peptide synthesis processes
- •Long-term safety data varies by indication and population studied
Peer-reviewed references
- Romani L, et al. — Thymosin alpha-1 mechanism review (2016)PMID: 27450734View
- Thymosin alpha-1 immunomodulatory effectsPMID: 25296849View
- COVID-19 cytokine modulation researchPMID: 33327170View
- Severe acute pancreatitis immunomodulation studiesPMID: 31912100View
- PMC7747025 — Comprehensive Tα1 mechanism and anti-tumor review
For research use only. This summary is a research-scientific overview compiled from peer-reviewed sources. It is not medical advice and is not intended for human or veterinary consumption.
Related products
